These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16034335)

  • 21. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent lacunar ischaemic stroke due to resistance to antiplatelet treatment: examining the need for personalised antithrombotic therapy.
    Delgado MG; Corte JR; Sáiz A; Calleja S
    Neurologia; 2015; 30(6):376-8. PubMed ID: 24332777
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 24. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Adding clopidogrel to standard treatment for acute myocardial infarction.
    Rotheray K
    Emerg Med J; 2010 Mar; 27(3):242-3. PubMed ID: 20304905
    [No Abstract]   [Full Text] [Related]  

  • 25. Digestion of the antiplatelets comparison of PRoFESS: 18-7=1?
    Algra A
    Stroke; 2009 May; 40(5):1932-5. PubMed ID: 19038908
    [No Abstract]   [Full Text] [Related]  

  • 26. Current challenges and directions in antithrombotic therapy.
    Van de Werf F
    Timely Top Med Cardiovasc Dis; 2008 Jan; 12():E2. PubMed ID: 18392216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent developments in the use of antiplatelet agents to prevent cardiovascular events.
    Lischke S; Schneider DJ
    Future Cardiol; 2011 May; 7(3):403-13. PubMed ID: 21627479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
    Gaspoz JM; de Moerloose P
    Am J Med; 2004 Jun; 116(12):850-2. PubMed ID: 15178502
    [No Abstract]   [Full Text] [Related]  

  • 31. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Images of an occlusive arterial disease of lower extremity due to chronic intoxication by ergot alkaloid.
    Baudoin Y; Guilhem K; Meyrat L; Thouard H
    J Vasc Surg; 2014 Sep; 60(3):785. PubMed ID: 25154965
    [No Abstract]   [Full Text] [Related]  

  • 33. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular pharmacology].
    Stiefelhagen P
    Internist (Berl); 2004 Oct; 45(10):1205-10. PubMed ID: 15322708
    [No Abstract]   [Full Text] [Related]  

  • 35. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Hiatt WR; Krantz MJ
    Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Erythrocyte concentrations of adenosine triphosphate (ATP) and magnesium, before and after conservative therapy of lower extremities atherosclerosis].
    Drozdz W; Kedryna T; Ostrowska B; Wilczek M; Stachurska B
    Pol Merkur Lekarski; 2004 Apr; 16(94):332-6. PubMed ID: 15517927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent antiplatelet and fibrinolytic therapy.
    Lange RA; Hillis LD
    N Engl J Med; 2005 Mar; 352(12):1248-50. PubMed ID: 15758001
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unstable angina guidelines expand use of clopidogrel, enoxaparin.
    Geriatrics; 2002 May; 57(5):64. PubMed ID: 12040596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.